If the justices of the United States Supreme Court give signals in the interrogations in their hearings, this time it follows that it seems unlikely that they will agree to restrict access to mifepristone. This is a key medication used in 60% of abortions performed in this country.
This medication was approved more than two decades ago, with no known side effects. But in this era of right-wing mobilization against abortion, mifepristone emerged as a target.
From the hearing held yesterday, and whose ruling will not be known until the summer, a majority of the judges, from both sides of the ideological spectrum, expressed skepticism in the face of the challenge of anti-abortion doctors, who question the relaxation of regulations by the Government .
The magistrates expressed their doubts that the plaintiffs have sufficient legal bases or standing to bring the case.
During the presentation of arguments, the Government attorneys and the pharmaceutical company’s lawyers emphasized the safety of the drug, but focused their responses on their reasoning to defend themselves against accusations that this drug is dangerous. They countered that multiple studies have overwhelmingly guaranteed its safety guarantee.
Conservative Justice Neil Gorsuch noted that this lawsuit is the result of the efforts of a handful of people, an example of what it means to turn a small lawsuit into a national issue at the expense of the Federal Food and Drug Administration (FDA).
He asked a key question, whether the doctors involved could show a person who was harmed due to the federal approval and regulation of mifepristone. “You need a person, so what is your person?” insisted progressive Justice Elena Kagan.
